HQY HealthEquity, Inc.

HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.

HealthEquity's 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.

HealthEquity (NASDAQ:HQY) posted second-quarter fiscal 2027 results on August 27, which pushed revenue growth to 8% year over year, up from the 7% pace set over the first half of the year, a rare acceleration for a company already sitting on 10.7 million health savings accounts/HSAs. Adjusted EBITDA jumped 11% to $167 million, translating into […]

Record profitability and accelerated invested asset growth signal durability.

Sales and earnings beats in fiscal Q2 weren't enough to satisfy investors.

HealthEquity (HQY) is back in focus after reporting second quarter results on 27 August 2026, along with higher full year guidance, a completed share repurchase tranche and a new employee stock plan related shelf registration. Despite the strong Q2 update and raised full year guidance, HealthEquity’s share price has pulled back sharply in the very short term, with a 1 day share price return of down 10.6% and a 7 day return of down 10.4%. That sits against a 90 day share price return of 6.1%...

HealthEquity stock has delivered a solid 5 year gain, yet current valuation checks send a mixed message as the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount while market based multiples look stretched. Recent share price weakness adds another layer, since the broader value score does not clearly classify the stock as either cheap or expensive. HealthEquity has returned 41.2% over 5 years, which suggests the longer term holders have still come out ahead...

HealthEquity Inc (HQY) delivers record Q2 results with 8% revenue growth and a 48% adjusted EBITDA margin, fueled by AI-driven efficiencies and strong HSA member engagement.

Moby summary of HealthEquity, Inc.'s Q2 2027 earnings call

HealthEquity (NASDAQ:HQY) reported accelerated revenue growth and record profitability in its fiscal 2027 second quarter, citing HSA account expansion, higher member engagement and technology-driven service efficiencies. The company raised its full-year outlook after generating record adjusted EBITD

HealthEquity’s second-quarter results combined higher revenue and earnings with record HSA accounts, assets and Adjusted EBITDA margin, prompting management to increase its full-year outlook. Key Investor TakeawaysHealthEquity (NASDAQ:HQY) raised fiscal 2027 guidance after second-quarter revenue increased 8% year over year to $350.

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) delivered earnings and revenue surprises of +4.20% and +0.14%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Beyond analysts' top-and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2026.

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of +70.59% and +33.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

GoodRx (GDRX) delivered earnings and revenue surprises of 0.00% and +3.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.